The metabolic syndrome and risk of coronary artery disease in patients with chronic schizophrenia or schizoaffective disorder in a chronic mental institute
Ching-kuan Wu
The Kaohsiung journal of medical sciences, 2014
View PDFchevron_right
The prevalence of cardiometabolic risk factors and the ten-year risk of fatal cardiovascular events in patients with schizophrenia and related psychotic disorders
Dita Protopopova
Psychiatria Danubina, 2012
View PDFchevron_right
Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: Findings from the CLAMORS study
Brian Kirkpatrick
European Neuropsychopharmacology, 2011
View PDFchevron_right
Cardiac risk factors and metabolic syndrome in patients with schizophrenia admitted to a general hospital psychiatric unit
subho chakrabarti
Indian Journal of Psychiatry 2014; 56: 371-376.
View PDFchevron_right
Metabolic syndrome and 10-year risk of cardiovascular events among schizophrenia inpatients treated with antipsychotics
Ali Dehghani
Medical Journal of The Islamic Republic of Iran, 2019
View PDFchevron_right
A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls
Jonathan Meyer
Schizophrenia Research, 2005
View PDFchevron_right
Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: A cross-sectional study in a low cardiovascular disease risk geographical area
MIGUEL ANGEL MONTES BERNARDO
European Psychiatry, 2009
View PDFchevron_right
Schizophrenia and increased risks of cardiovascular disease
Danielle Hollar
American Heart Journal, 2005
View PDFchevron_right
Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia
Jari Tiihonen
Psychological Medicine, 2012
View PDFchevron_right
Coronary heart disease risk in patients with schizophrenia: a Lebanese cross-sectional study
Marouan Zoghbi, Pascale Salameh
View PDFchevron_right
A comprehensive cardiovascular disease risk profile in patients with schizophrenia
Gunnar Morken
Scandinavian Journal of Medicine & Science in Sports, 2019
View PDFchevron_right
Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study
Sven Eriksson
View PDFchevron_right
Eight-year trends of cardiometabolic morbidity and mortality in patients with schizophrenia
Stephen Bartels
General Hospital Psychiatry, 2012
View PDFchevron_right
Schizophrenia and the incidence of cardiovascular morbidity: A population-based longitudinal study in Ontario, Canada
Centro Dharma Tampico
Schizophrenia Research, 2009
View PDFchevron_right
Estimation of Cardiovascular Risk by Framingham Score in a Cross-sectional Sample of Schizophrenia Inpatients
catalina crisan
Medicina Moderna - Modern Medicine
View PDFchevron_right
Monitoring and management of cardiometabolic risk factors in schizophrenia- A global perspective: rationale, aims and methods
joyce omoaregba, Padmavati Ramachandran
View PDFchevron_right
revalence of Metabolic Syndrome in Patients with Schizophrenia Referred to Farabi Hospital, Kermanshah, Iran
vahid farnia
Oman Medical Journal, 2016
View PDFchevron_right
Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: Results of the CLAMORS Study
Julio Bobes
Schizophrenia Research, 2007
View PDFchevron_right
Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study
Silvana Galderisi
European Psychiatry
View PDFchevron_right
Investigation of the Relationship of Sociodemographic and Clinical Characteristics with Cardiovascular Risk Scores in Patients with Schizophrenia Living in Nursing Homes
Rümeysa Taşdelen
Sakarya tıp dergisi, 2023
View PDFchevron_right
Erratum to: The prevalence and clinical correlates of metabolic syndrome in patients with schizophrenia: findings from a cohort in Turkey
Ergun Karaagaoglu
European Archives of Psychiatry and Clinical Neuroscience, 2011
View PDFchevron_right
Assessment of risk for cardiovascular disease in a sample of schizophrenic patients
Mamdouh Elgamal
Egyptian Journal of Psychiatry, 2017
View PDFchevron_right
Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study
Sue Estroff
JAMA psychiatry, 2014
View PDFchevron_right
A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: Findings from the CLAMORS study
Javier Rejas
Schizophrenia Research, 2008
View PDFchevron_right
Schizophrenia and the Metabolic Syndrome
Jared Reser
View PDFchevron_right
Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis
Alex J Mitchell
Schizophrenia bulletin, 2013
View PDFchevron_right